Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
A guide to assessing the impact, risk and requirements of the change.
Expedited and harmonised pathways for innovative therapies.
Considerations for development through 2040.
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
7 October 2025 Register now.
22 October 2025 Register now
ICON CARES is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
1:00:08
In collaboration with DIA and CitiusTech, Inc.
1:02:35
1:03:09
57:55
1:00:22
51:34
1:03:51
